Pregnancy Outcomes in Polycystic Ovary Syndrome

多囊卵巢综合症的妊娠结局

基本信息

  • 批准号:
    7210187
  • 负责人:
  • 金额:
    $ 50.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-06-01 至 2010-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among reproductive-age women, affecting ~5-10 percent of women in the general population. Clinical features of PCOS include chronic anovulation, androgen excess, and polycystic ovaries, with insulin resistance considered a central factor. In women with PCOS who do get pregnant, limited data suggest there may be a higher incidence of pregnancy complications, including gestational diabetes and hypertensive disorders. However, these investigations have been conducted in only selected groups and there have been no large population-based studies of pregnancy outcomes among women with PCOS, and extremely limited data on relevant neonatal outcomes. The membership of Kaiser Permanente Northern California, one of the largest integrated health care delivery systems in the US, presents a unique opportunity to investigate the epidemiology and pregnancy-related outcomes of women with diagnosed PCOS within a large multiethnic population. Using the Kaiser Permanente PCOS Registry, which includes -13,000 women with diagnosed PCOS, in addition to automated electronic data sources and targeted chart review, we propose to evaluate whether specific gestational and neonatal adverse outcomes are associated with PCOS, and potential mediating factors. The three Specific Aims of our study are the following: AIM 1. To evaluate the effects of PCOS status on the incidence of gestational diabetes, gestational hypertension, and pre-ecclampsia/ecclampsia among pregnant women. AIM 2. Among the subset of women with PCOS who become pregnant, to identify clinical, metabolic and reproductive factors which predict an increased risk of gestational diabetes and pre-ecclampsia/ecclampsia. AIM 3. To evaluate the association of maternal PCOS status with the incidence of adverse neonatal outcomes, including macrosomia, premature delivery and neonatal intensive care unit (NICU) admission. Secondarily, we will evaluate the association of PCOS status with the incidence of small-for-gestational-age infants and overall neonatal mortality. The proposed study will provide a rigorous evaluation of the impact of PCOS on pregnancy-related and neonatal outcomes and hopefully yield insights into better risk stratification and development of therapeutic strategies designed to improve perinatal outcomes among the growing population of women with PCOS.
描述(由申请人提供):多囊卵巢综合征(PCOS)是育龄妇女中最常见的内分泌疾病之一,影响一般人群中约5- 10%的妇女。多囊卵巢综合征的临床特征包括慢性无排卵、雄激素过多和多囊卵巢,胰岛素抵抗被认为是一个中心因素。在怀孕的PCOS妇女中,有限的数据表明可能有更高的妊娠并发症发生率,包括妊娠期糖尿病和高血压疾病。然而,这些研究仅在选定的组中进行,并且没有对PCOS妇女的妊娠结局进行大规模基于人群的研究,并且有关新生儿结局的数据非常有限。Kaiser Permanente北方加州是美国最大的综合医疗保健提供系统之一,该组织的成员资格为研究多种族人群中确诊为PCOS的女性的流行病学和妊娠相关结局提供了独特的机会。使用Kaiser Permanente PCOS登记处,其中包括约13,000名诊断为PCOS的女性,除了自动化电子数据源和有针对性的图表审查外,我们建议评估特定的妊娠和新生儿不良结局是否与PCOS相关,以及潜在的介导因素。我们研究的三个具体目标如下:目标1。评估PCOS状态对妊娠期糖尿病、妊娠期高血压和先兆子痫/子痫发生率的影响。AIM 2.在怀孕的PCOS女性中,确定预测妊娠期糖尿病和先兆子痫/子痫风险增加的临床、代谢和生殖因素。AIM 3.评估母亲PCOS状态与新生儿不良结局发生率的关系,包括巨大儿、早产和新生儿重症监护室(NICU)入院。其次,我们将评估PCOS状态与小于胎龄儿发生率和总体新生儿死亡率的关系。这项拟议的研究将对PCOS对妊娠相关和新生儿结局的影响进行严格的评估,并有望深入了解更好的风险分层和治疗策略的制定,旨在改善日益增长的PCOS妇女的围产期结局。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joan C Lo其他文献

Fracture Risk and Association With TDF Use Among People With HIV in Large Integrated Health Systems
大型综合卫生系统中 HIV 感染者的骨折风险及其与 TDF 使用的关联
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    R. Hechter;Hui Zhou;W. Leyden;Qing Yuan;Katherine J. Pak;Jennifer O. Lam;Stacey E Alexeeff;Alexandra N. Lea;Haihong Hu;Julia L. Marcus;Adovich S Rivera;Annette L. Adams;M. Horberg;W. Towner;Joan C Lo;Michael J. Silverberg
  • 通讯作者:
    Michael J. Silverberg
The Digital Transition: Are Adults Aged 65 Years or Older Willing to Complete Online Forms and Questionnaires in Patient Portals?
数字化转型:65 岁或以上的成年人愿意在患者门户网站上填写在线表格和调查问卷吗?
  • DOI:
    10.7812/tpp/23.112
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nancy P Gordon;Sherry Zhang;Joan C Lo;Christina F Li
  • 通讯作者:
    Christina F Li
Examining Whether Patient Portal and Video Visit Use Differs by Race and Ethnicity Among Older Adults in a US Integrated Health Care Delivery System: Cross-Sectional Electronic Health Record and Survey-Based Study
在一个美国综合医疗保健提供系统中,检查老年患者使用患者门户和视频就诊是否因种族和民族而异:基于电子健康记录和调查的横断面研究
  • DOI:
    10.2196/63814
  • 发表时间:
    2024-01-01
  • 期刊:
  • 影响因子:
    4.800
  • 作者:
    Nancy P Gordon;Chelsea Yin;Joan C Lo
  • 通讯作者:
    Joan C Lo

Joan C Lo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joan C Lo', 18)}}的其他基金

Skeletal Health Outcomes among US Asian Women
美国亚裔女性的骨骼健康状况
  • 批准号:
    10665062
  • 财政年份:
    2021
  • 资助金额:
    $ 50.23万
  • 项目类别:
Skeletal Health Outcomes among US Asian Women
美国亚裔女性的骨骼健康状况
  • 批准号:
    10096288
  • 财政年份:
    2021
  • 资助金额:
    $ 50.23万
  • 项目类别:
Femur Fracture Outcomes Associated with Bisphosphonate Use
与双磷酸盐使用相关的股骨骨折结果
  • 批准号:
    8818973
  • 财政年份:
    2015
  • 资助金额:
    $ 50.23万
  • 项目类别:
Femur Fracture Outcomes Associated with Bisphosphonate Use
与双磷酸盐使用相关的股骨骨折结果
  • 批准号:
    9191332
  • 财政年份:
    2015
  • 资助金额:
    $ 50.23万
  • 项目类别:
ESRD Endocrinopathy and Daily Dialysis
ESRD 内分泌疾病和每日透析
  • 批准号:
    8119109
  • 财政年份:
    2010
  • 资助金额:
    $ 50.23万
  • 项目类别:
ESRD Endocrinopathy and Daily Dialysis
ESRD 内分泌疾病和每日透析
  • 批准号:
    8332114
  • 财政年份:
    2010
  • 资助金额:
    $ 50.23万
  • 项目类别:
Pregnancy Outcomes in Polycystic Ovary Syndrome
多囊卵巢综合症的妊娠结局
  • 批准号:
    7650015
  • 财政年份:
    2007
  • 资助金额:
    $ 50.23万
  • 项目类别:
Pregnancy Outcomes in Polycystic Ovary Syndrome
多囊卵巢综合症的妊娠结局
  • 批准号:
    7430262
  • 财政年份:
    2007
  • 资助金额:
    $ 50.23万
  • 项目类别:
BONE MINERAL DENSITY AND BONE METABOLISM IN HIV
HIV 患者的骨矿物质密度和骨代谢
  • 批准号:
    7203023
  • 财政年份:
    2004
  • 资助金额:
    $ 50.23万
  • 项目类别:
Bone mineral density and bone metabolism in HIV
HIV 患者的骨矿物质密度和骨代谢
  • 批准号:
    7044932
  • 财政年份:
    2003
  • 资助金额:
    $ 50.23万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 50.23万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 50.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 50.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 50.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 50.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 50.23万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 50.23万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 50.23万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 50.23万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 50.23万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了